Skip to content

Carbon Dioxide Infusion:Clinical and Histological Appraisal in Chronic Wounds

Carbon Dioxide Infusion:Clinical and Histological Appraisal in Chronic Wounds

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01864967
Enrollment
10
Registered
2013-05-30
Start date
2007-03-31
Completion date
2008-08-31
Last updated
2013-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Wounds

Keywords

carbon dioxide infusion, dilatation of peripheral blood vessels, capillaries, macrophags, fibroblasts, Improvement granulation tissue in chronic wounds

Brief summary

Carbon dioxide infusion is a non surgical procedure applied via percutaneous, transdermal and subcutaneous. Increase in the concentration of carbon dioxide decreases pH activating local nitric oxide that stimulates collateral vessels formation, vascular endothelial growth factor and basic fibroblast growth factor. Carbon dioxide infusion restores the blood flow in chronic wounds of the lower limbs.

Detailed description

Ten patients with chronic wounds caused by venous insufficiency at both lower limbs were distributed into groups. Group I was composed by wounds in the right lower limb that received carbon dioxide and group II by wounds in the left lower limb that not received carbon dioxide, both related to the same patient. Carbon dioxide infusion was performed with the needle pointed toward the granulation tissue, 5cm distant from each one at intervals of 4 days. Biopsies were collected from the wounds before carbon dioxide infusion and after the 3rd, 5th and 10th application. Statistical analysis of the data was performed using Wilcoxon's test and Friedman's variance analysis and multiple comparisons test.

Interventions

None listed

Sponsors

Institute of Assistance in Plastic Surgery, Sao Paulo
Lead SponsorOTHER

Study design

Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
49 Years to 59 Years
Healthy volunteers
Yes

Inclusion criteria

* chronic wounds caused by venous insufficiency

Exclusion criteria

* other diseases of the lower limbs

Design outcomes

Primary

MeasureTime frame
dilatation of peripheral blood vessels, number of capillaries, macrophages and fibroblasts10 sessions (5 weeks) per patient

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026